|
FY2026
12 months to Jul 31, 2026
|
FY2025
12 months to Jul 31, 2025
|
FY2024
12 months to Jul 31, 2024
|
FY2023
12 months to Jul 31, 2023
|
FY2022
12 months to Jul 31, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Bad debt expense | |||||
| Provision (benefit) for deferred income tax | |||||
| Net realized (gain) on sale of marketable securities | |||||
| Depreciation | |||||
| Loss on fixed asset disposal | |||||
| Amortization of deferred charges | |||||
| Operating lease expense in excess of cash payments | |||||
| Deferred finance costs included in interest expense | |||||
| Receivables | |||||
| Deferred costs | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Security deposits payable | |||||
| Cash provided by operating activities | |||||
| Cash Flows From Investing Activities: | |||||
| Acquisition of property and equipment | |||||
| Receipts from sales | |||||
| Payments for purchases | |||||
| Cash (used) in investing activities | |||||
| Proceeds – mortgages | |||||
| Payments – mortgages | |||||
| Payments – financing costs | |||||
| Cash provided (used) in financing activities | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
Loading...